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Abstract
Type I interferons (including IFNαβ) are innate cytokines that may contribute to pathogene-
sis duringMycobacterium tuberculosis (Mtb) infection. To induce IFNβ, Mtb must gain
access to the host cytosol and trigger stimulator of interferon genes (STING) signaling. A
recently proposed model suggests that Mtb triggers STING signaling through bacterial DNA
binding cyclic GMP-AMP synthase (cGAS) in the cytosol. The aim of this study was to test
the generalizability of this model using phylogenetically distinct strains of the Mtb complex
(MTBC). We infected bone marrow derived macrophages with strains from MTBC Lineages
2, 4 and 6. We found that the Lineage 6 strain induced less IFNβ, and that the Lineage 2
strain induced more IFNβ, than the Lineage 4 strain. The strains did not differ in their access
to the host cytosol and IFNβ induction by each strain required both STING and cGAS. We
also found that the three strains shed similar amounts of bacterial DNA. Interestingly, we
found that the Lineage 6 strain was associated with less mitochondrial stress and less mito-
chondrial DNA (mtDNA) in the cytosol compared with the Lineage 4 strain. Treating macro-
phages with a mitochondria-specific antioxidant reduced cytosolic mtDNA and inhibited
IFNβ induction by the Lineage 2 and 4 strains. We also found that the Lineage 2 strain did
not induce more mitochondrial stress than the Lineage 4 strain, suggesting that additional
pathways contribute to higher IFNβ induction. These results indicate that the mechanism for
IFNβ by Mtb is more complex than the established model suggests. We show that mito-
chondrial dynamics and mtDNA contribute to IFNβ induction by Mtb. Moreover, we show
that the contribution of mtDNA to the IFNβ response varies by MTBC strain and that addi-
tional mechanisms exist for Mtb to induce IFNβ.
Author Summary
Bacterial strains from theMycobacterium tuberculosis complex (MTBC) infect one in
three humans, however not all infected individuals progress to active tuberculosis disease.
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It is unknown why immunocompetent individuals develop tuberculosis, and this presents
a significant challenge in preventing the disease. One proposed explanation is that individ-
uals that progress produce higher levels of the innate cytokine type I interferon, due to
bacterial and/or host determinants. Therefore we set out to determine whether MTBC
strains from distinct phylogenetic lineages induce distinct levels of type I interferon, and
to determine a mechanism of type I interferon induction by each strain. We found that a
Lineage 6 strain induced lower levels of type I interferon in macrophages than Lineage 2
and 4 strains. Additionally, this strain induced low levels of mitochondrial stress. We
showed that improving mitochondrial function by treating macrophages with a mitochon-
dria-specific antioxidant reduced type I interferon induction by Lineage 2 and 4 strains.
Our results indicate that differential mitochondrial stress contributes to differential type I
interferon induction by distinct MTBC strains. This suggests that mitochondria-specific
antioxidants may be a means of reducing the pathogenic type I interferon response.
Introduction
Type I interferons (including IFNαβ) are innate cytokines that are protective during most viral
infections, but may be pathogenic during infections with bacteria such asMycobacterium
tuberculosis (Mtb) [1]. Studies have shown that active tuberculosis (TB) is associated with
expression of interferon-inducible genes [2, 3], lepromatousMycobacterium leprae lesions are
enriched in IFNαβ-inducible mRNAs [4], and that interleukin-1 confers resistance to Mtb by
limiting IFNαβ induction [5]. There is also evidence that IFNαβ is protective in certain con-
texts [6], and thus it is likely that a balance of this cytokine is required for optimal protection.
Given the complex role of IFNαβ signaling during Mtb infection, discovering a model for how
Mtb induces IFNβ gene transcription—the first step required for IFNαβ signaling—has been
an active and challenging area of research.
Several groups have recently proposed a mechanism for IFNβ induction by Mtb. In this
model, the first step in the pathway occurs when Mtb gains access to the host cytosol [7], such
as through phagosome permeabilization [8]. The second step is initiation of the STING (stimu-
lator of interferon genes) signaling pathway. STING can be triggered by bacterial cyclic dinu-
cleotides [9] or through DNA binding to cGAS (cyclic GMP-AMP synthase) in the cytosol
[10–12]. The established model suggests that bacterial DNA shed from cytosolic mycobacteria
binds to and activates cGAS in order to induce IFNβ [12, 13]. However, this model does not
take into account the contribution of DNA from other sources, such as mitochondria. Further-
more, this model has only been tested with strains fromMTBC Lineage 4 and it is unknown
whether the mechanism is generalizable to strains from other phylogenetic lineages.
The two important outstanding questions that we address in this study are: 1) Do phyloge-
netically distinct mycobacterial strains induce distinct levels of IFNβ in vitro? and 2) What are
the mechanisms underlying IFNβ induction by these strains? Identifying a mechanism by
which distinct MTBC strains promote IFNαβ induction would provide crucial insight into a
mechanism of Mtb pathogenesis and into the evolution and diversity of mycobacterial strains.
Therefore, in order to examine the model for IFNβ induction by Mtb, we infected bone mar-
row derived macrophages (BMDM) with bacterial strains from three phylogenetically distinct
MTBC lineages and assayed cytosolic signaling and IFNβ induction by each. The MTBC strains
we chose were 1182 (Lineage 6; also known asM. africanum) [14, 15], H37Rv (Lineage 4) [16],
and 4334 (Lineage 2) [17, 18] (S1 Table). We find that 1182/Lineage 6 induces significantly
less, and 4334/Lineage 2 induces significantly more, IFNβ than H37Rv/Lineage 4. Additionally,
Type I Interferon Induction by Distinct Mycobacterial Strains
PLOS Pathogens | DOI:10.1371/journal.ppat.1005809 August 8, 2016 2 / 20
we find that strain differences in IFNβ induction are not due to differences in cytosolic access
or bacterial DNA shedding. Instead, we provide evidence that IFNβ differences are due, at least
partially, to differences in mitochondrial stress and mitochondrial DNA (mtDNA) in the cyto-
sol. Moreover, we show that additional mechanisms exist for Mtb to induce IFNβ and thus that
the mechanism for IFNβ induction by Mtb is much more complex than the established model
has implied.
Results
IFNβ induction is bacterial strain-dependent during Mtb infection
To determine whether distinct mycobacterial strains induce distinct levels of IFNβ in vitro, we
infected bone marrow derived macrophages (BMDM) with strains from three distinct phyloge-
netic lineages (S1 Table). We found that 1182/Lineage 6 induced less IFNβ, and 4334/Lineage 2
induced more IFNβ, than H37Rv/Lineage 4 (Fig 1). Differences in mRNA expression were
detected at 3 hr post infection and continued at 6 and 24 hr post infection (Fig 1A). Differences
in secreted protein were detected at 48 hr post infection and were consistent across several mul-
tiplicities of infection (MOI) (Fig 1B). The H37Rv ΔEsx-1 strain that is unable to access the
cytosol [8, 19] did not induce IFNβ (Fig 1A and 1B).
Importantly, the differences in IFNβ protein secretion were not due to differences in bacte-
rial numbers or intracellular survival (Fig 1C), and were not mirrored by differences in tumor
necrosis factor (TNF) secretion (Fig 1D). To verify this, we included colony forming units
(CFU) and TNF as covariates in an ANCOVAmodel (S2 Table). We found that CFU and TNF
did not explain variation in IFNβ, while bacterial strain did, at each MOI. This suggested that
IFNβ induction by Mtb was bacterial strain-dependent and that strain differences were not
explained by differences in bacterial growth or accompanied by global differences in inflamma-
tory cytokine production. We also assayed interleukin-1 (IL-1) secretion, which negatively reg-
ulates IFNβ [5]. We found that IL-1 levels were below the limit of detection during infection
with each strain, and thus variation in IL-1 likely did not explain IFNβ variation in this system.
Therefore we hypothesized that differences in IFNβ induction were due to differences in cyto-
solic signaling.
Access to the host cytosol does not vary by mycobacterial strain
To induce IFNβ gene transcription, Mtb must gain access to the host cytosol [7]. To determine
whether cytosolic access varied by mycobacterial strain, we infected BMDM and assayed colo-
calization of each strain with FK2 and Galectin-3. FK2 labels ubiquitinated proteins and thus
labels bacteria that gain access to the cytosol and are ubiquitinated [20]. Galectin-3 labels dam-
aged vacuole membranes [21]. There were no detectable differences in the percent of bacteria
that colocalized with FK2 (Fig 2A and 2C) or Galectin-3 (Fig 2B and 2D) at any time point
examined during infection with 1182/Lineage 6, H37Rv/Lineage 4, or 4334/Lineage 2. 4334/
Lineage 2 interacted differently with FK2 and Galectin-3 than 1182/Lineage 6 and H37Rv/
Lineage 4, as indicated by staining patterns (Fig 2A and 2B), however this was not associated
with IFNβ induction. In addition, we measured the mean fluorescence intensity (MFI) of FK2
and Galectin-3 surrounding each colocalized bacterium and found no significant differences
between the strains (Fig 2E and 2F). The ΔEsx-1 negative control strain did not colocalize with
FK2 or Galectin-3. These data suggested that the differences in IFNβ induction between MTBC
strains were not attributable to differences in access of the bacteria to the cytosol.
We confirmed these results using a LiveBLAzer FRET assay [8]. In this assay BMDM are
incubated with Cephalosporin Coumarin Fluorescein 4 (CCF4), a cephalosporin substrate
labeled with two fluorophores that form a fluorescent resonance energy transfer (FRET) pair.
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Fig 1. IFNβ induction is bacterial strain-dependent during Mtb infection. A) BMDMwere infected with the indicated mycobacterial strains at an
MOI of 5 or stimulated with LPS (10 ng/mL). RNA was harvested for IFNβmRNA quantification by qRT-PCR at 3, 6, and 24 hr post infection. *p<0.05,
**p<0.01, ****p<0.0001 by two-way repeated measures ANOVA with Tukey post-tests; means ± SD (n = 3). B) BMDMwere infected with the
indicated bacterial strains at MOI of 1, 5, and 10 or stimulated with LPS (10 ng/mL). Supernatants were collected for IFNβ protein quantification by
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In BMDM where Mtb is sequestered in a phagosome, CCF4 is uncleaved and when excited at
409 nm emits fluorescence with a peak at 520 nm. In BMDM where Mtb gains access to the
cytosol, Mtb’s endogenous β-lactamase cleaves CCF4 and disrupts the FRET signal and phago-
some permeabilization is detected by BMDM that emit a signal at 450 nm. We found no differ-
ence in 450:520 nm fluorescence ratios between the three MTBC strains (S1 Fig), which
confirmed the FK2 and Galectin-3 results. Together, these data indicated that differences in
IFNβ induction between the MTBC strains were not due to differences in access to the host
cytosol.
IFNβ induction by each MTBC strain is dependent on STING and cGAS
Once Mtb gains access to the cytosol it triggers STING signaling, either by bacterial cyclic dinu-
cleotides [9] or through dsDNA binding to and activating cGAS in the cytosol [10–12]. To
determine whether IFNβ induction by each strain was dependent on STING signaling we
infected STING-/- and wild type BMDM and assayed IFNβ protein secretion. We found that
IFNβ induction by each strain was completely abrogated in the absence of STING (Fig 3A),
indicating that IFNβ induction was STING-dependent, and suggested that under these condi-
tions differential production of cGAMP or release of DNA into the cytosol may contribute to
differential IFNβ induction.
Next we determined whether IFNβ induction by each strain was due to direct STING signal-
ing or due to STING signaling via cGAS. Therefore we infected cGAS-/- and wild type BMDM
and assayed IFNβ protein secretion. We found that IFNβ induction by each strain was reduced
in the absence of cGAS to the same degree that IFNβ induction was reduced in the absence of
STING (Fig 3B). These data suggested that differences in IFNβ induction between the MTBC
strains might depend on differences in the availability of cytosolic DNA for binding to and acti-
vating cGAS.
Release of host, but not bacterial, DNA into the cytosol is bacterial
strain-dependent during Mtb infection
cGAS is a cytosolic DNA sensor that can recognize dsDNA of microbial, nuclear or mitochon-
drial origin [22, 23]. To determine whether accumulation of dsDNA in the cytosol was myco-
bacterial strain-dependent we infected BMDM with each MTBC strain and quantified
cytosolic DNA following cell fractionation. We found that infection with H37Rv/Lineage 4 was
associated with increased mitochondrial and nuclear DNA in the cytosol compared with 1182/
Lineage 6 (Fig 4A and 4B), and we found no differences in release of bacterial DNA (Fig 4C
and 4D). The procedure for preparing subcellular fractions to quantitate DNA permeabilized
phagosome membranes as well as the plasma membrane, as is indicated by bacterial DNA
detected in the cytosolic fraction of cells infected with the ΔEsx-1 mutant (Fig 4C and 4D). To
verify that the fractionation buffer did not permeabilize other organelle membranes, we used
immunoblotting to determine that the mitochondrial proteins Complex Vα (CVα) and pyru-
vate dehydrogenase E1α (PDH) remained in the organelle fractions and were not found in the
cytosol fractions (Fig 4E).
Given these data we hypothesized that reduced IFNβ induction by 1182/Lineage 6 was due
to reduced mtDNA in the cytosol. Although we also found reduced nuclear DNA in the cytosol
ELISA at 48 hr post infection. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by one-way ANOVA with Tukey post-tests for each MOI; means ± SD
(n = 3). Results are representative of 3 independent experiments. C-D) Cell lysates from the experiment shown in Fig 1B were collected at 3, 24, and 48
hr post infection. Colony forming units (CFU) were quantified by serial dilution on 7H11 agar plates. CFU for each MOI at each time point are plotted on
the x-axes and the corresponding IFNβ (C) and TNF (D) secretion at 48 hr post infection is plotted on the y-axes.
doi:10.1371/journal.ppat.1005809.g001
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of 1182/Lineage 6-infected cells, a recent study has shown that mtDNA–and not nuclear
DNA–stimulates IFNβ induction [24]. We further hypothesized that the reduced mtDNA in
the cytosol was due to reduced mitochondrial stress in cells infected with 1182/Lineage 6.
Release of host DNA into the cytosol during Mtb infection is associated
with mitochondrial stress
MtDNAmay accumulate in the cytosol under conditions of stress [25–27], and mitochondrial
stress and mtDNA have been implicated in IFNβ induction [24, 28–31]. To determine whether
the release of mtDNA into the cytosol was associated with mitochondrial stress, we infected
BMDM with each Mtb strain and quantified ATP as a measure of the bioenergetic state of the
cell. We infected BMDM cultured in media lacking glucose and supplemented with galactose
to prevent BMDM from using glycolysis for ATP production. We found that 1182/Lineage 6
was associated with higher cellular ATP concentrations compared with H37Rv/Lineage 4, with
ATP levels similar to uninfected cells and the negative control ΔEsx-1 (Fig 4F). This suggested
that 1182/Lineage 6 infection might induce especially low levels of mitochondrial stress. These
data were consistent with the finding of lesser quantities of mtDNA in the cytosol of BMDM
infected with 1182/Lineage 6 (Fig 4A).
To further examine mitochondrial stress, we quantified superoxide production in BMDM
following infection with each bacterial strain. Superoxide is a reactive oxygen species (ROS)
that is a byproduct of mitochondrial oxidative phosphorylation as electrons that leak from the
electron transport chain are transferred to molecular oxygen. Conditions of stress result in an
Fig 2. Access to the host cytosol does not vary bymycobacterial strain. A-B) BMDMwere infected with the indicated dsRed-expressing
mycobacterial strains at an MOI of 1. BMDMwere fixed overnight and stained for FK2 and Galectin-3 at 3, 12, 24, and 48 hr post infection. Representative
images are shown for FK2 colocalization at 48 hr post infection (A) and Galectin-3 colocalization at 24 hr post infection (B), with bacteria shown in
magenta and FK2 and Galectin-3 shown in green. C-D) 10 images were captured at 100x magnification for each chamber well and the percent of bacteria
that colocalized with FK2 (C) and Galectin-3 (D) was calculated for each strain. E-F) Mean fluorescence intensity (MFI) of the FK2 (E) and Galectin-3 (F)
staining directly surrounding each colocalized bacterium was calculated using ImageJ. Results are representative of 1–3 independent experiments. All
differences in percent colocalization and MFI between 1182, H37Rv, and 4334 were not significant (p>0.05) by two-way repeated measures ANOVA with
Tukey post-tests; means ± SD (n = 4).
doi:10.1371/journal.ppat.1005809.g002
Fig 3. IFNβ induction by each MTBC strain is dependent on STING and cGAS. A) Wild type and STING-/- BMDMwere infected with the indicated
mycobacterial strains at an MOI of 5. Supernatants were collected for IFNβ protein quantification by ELISA at 48 hr post infection. B) Wild type and
cGAS-/- BMDMwere infected with the indicated bacterial strains at an MOI of 5. Supernatants were collected for IFNβ protein quantification by ELISA at
48 hr post infection. ****p<0.0001 by two-way ANOVA with Tukey post-tests; means ± SD (n = 3).
doi:10.1371/journal.ppat.1005809.g003
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Fig 4. Release of host, but not bacterial, DNA into the cytosol is mycobacterial strain-dependent and is associated with mitochondrial stress.
A-D) BMDMwere infected with the indicated mycobacterial strains at an MOI of 5. 24 hr post infection, cells were collected and fractionated.
Mitochondrial (A), nuclear (B), and bacterial (C,D) DNA in cytosolic fractions was quantified using gene-specific primers and normalized to the amount of
each gene in lysates of unfractionated cells (shown as %). *p<0.05, **p<0.01 by one-way ANOVA with Tukey post-tests; means ± SD (n = 3). E)
Mitochondrial proteins (CVα and PDH) in the organelle and cytosolic fractions were quantified on immunoblots. β-actin was used as the cytosolic loading
control. Results are representative of 2 independent experiments. F) BMDMwere cultured in the presence of galactose and absence of glucose for 24 hr
and then infected with the indicated mycobacterial strains at MOI of 1, 5, and 10. 24 hr post infection luciferase and luciferin were added to cell lysates
and ATP production was measured by luminescence. *p<0.05, **p<0.01, ***p<0.001 by one-way ANOVA with Tukey post-tests for each MOI;
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increase in the number of leaking electrons and result in accumulation of superoxide [32, 33].
We found reduced mitochondrial superoxide production during 1182/Lineage 6 infection
compared to H37Rv/Lineage 4 (Fig 4G and 4H). This supported our conclusion that 1182/
Lineage 6 was associated with reduced mitochondrial stress.
Importantly, we also found that 4334/Lineage 2 was associated with less host DNA in the cytosol
(Fig 4A and 4B) and less mitochondrial stress (Fig 4F and 4G) than H37Rv/Lineage 4. This indi-
cated that 4334/Lineage 2 induced high IFNβ levels by a different, additional mechanism.
Mitochondrial stress and cytosolic mtDNA contribute to IFNβ induction
by MTBC strains
Several studies have shown that mitochondrial ROS-induced oxidation of DNA contributes to
the inflammatory response to DNA [25, 30, 34, 35]. Our data suggest that this may also be true
for the IFNβ response to mycobacterial infection (Figs 1 and 4). To determine whether mycobac-
terial strain-dependent differences in IFNβ were due to differential accumulation of ROS, we
treated BMDMwith the antioxidant MitoQ and assayed accumulation of cytosolic DNA and
IFNβ protein secretion induced by each strain. MitoQ is coenzyme Q attached to a lipophilic tri-
phenylphosphonium cation. Coenzyme Q is a strong reducing agent and thus acts as an antioxi-
dant by transferring electrons to superoxide. The lipophilic cation causes accumulation of the
molecule specifically in the mitochondria [36]. We used decyltriphenylphosphonium bromide
(dTPP) as the negative control. We found that MitoQ treatment partially reduced superoxide
accumulation (Fig 5A and 5B). Higher doses of MitoQ were toxic to the cells and therefore we
were not able to completely eliminate superoxide accumulation. Correspondingly, we found that
MitoQ treatment reduced mtDNA accumulation in the cytosol during H37Rv/Lineage 4 and
4334/Lineage 2 infections (Fig 5C), but did not impact accumulation of bacterial DNA (Fig 5E).
MitoQ treatment also reduced nuclear DNA accumulation in the cytosol, but the levels of nuclear
DNA in the cytosol were lower than the levels of mtDNA (Fig 5D). MitoQ treatment had no sig-
nificant effect on total cellular levels of mitochondrial, nuclear, or bacterial DNA (Fig 5F–5H).
Furthermore, we found that MitoQ treatment partially reduced IFNβ induction by H37Rv/
Lineage 4 and 4334/Lineage 2 (Fig 6A), and that the percent of IFNβ inhibited by MitoQ treat-
ment was positively correlated with the amount of IFNβ a strain induced (Pearson r = 0.88,
p = 0.002 and Fig 6C and 6E). IFNβ reduction during MitoQ treatment was not mirrored by a
reduction in TNF (Fig 6B and 6D) or by a reduction in CFU (Fig 6F). In addition, the amount
of mtDNA in the cytosol of infected cells positively correlated with IFNβ induction (Pearson
r = 0.73, p = 0.0006 and S2 Fig), while bacterial DNA did not (Pearson r = -0.23, p = 0.36 and
S2 Fig). Nuclear DNA in the cytosol also correlated with IFNβ induction, but the correlation
was not a strong as for mtDNA (Pearson r = 0.60, p = 0.01 and S2 Fig). These data indicated
that IFNβ induction by the MTBC strains was due, at least in part, to mitochondrial stress and
cytosolic mtDNA accumulation.
Discussion
In this study we show that theM. tuberculosis complex strain 1182 from Lineage 6 induces less
mitochondrial ROS, less mtDNA in the cytosol, and lower IFNβ induction than H37Rv/
means ± SD (n = 3). G-H) BMDMwere infected with the indicated GFP-expressing mycobacterial strains at an MOI of 5. Live BMDMwere stained with
MitoSOX at 24 hr post infection and then fixed overnight. G) Representative images are shown, with Mtb shown in green and MitoSOX shown in red. H) 5
pictures were taken at 60x magnification for each chamber well and mean fluorescence intensity (MFI) of MitoSOX was determined for each infected
BMDM using ImageJ. Results are representative of 3 independent experiments. *p<0.05, **p<0.01 by one-way ANOVA with Tukey post-tests;
means ± SD (n = 3).
doi:10.1371/journal.ppat.1005809.g004
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Lineage 4. Further, we show that reducing mitochondrial ROS during Mtb infection reduces
IFNβ induction. Therefore we propose that mitochondrial stress contributes to IFNβ induction
by Mtb (Fig 7). We also show that 4334/Lineage 2 induces similar to lower levels of mitochon-
drial ROS and cytosolic mtDNA than H37Rv/Lineage 4, yet induces higher IFNβ induction.
Thus we propose that 4334/Lineage 2 induces additional, unidentified pathways to promote
Fig 5. Mitochondrial stress contributes to accumulation of mtDNA in the cytosol during H37Rv/Lineage 4 and 4334/Lineage 2 infections. A-H)
BMDMwere treated with MitoQ or control (dTPP) for 4 hours and then infected with the indicated mycobacterial strains at an MOI of 5. A) Uninfected
cells were stained with MitoSOX at the time of infection. B) Mean fluorescence intensity (MFI) of MitoSOX was determined using ImageJ. C-H) 24 hr post
infection, cells were collected and fractionated. Amount of DNA in cytosolic (C-E) and undisturbed cell (F-H) fractions was determined using gene-
specific primers as in Fig 4A–4D; amount in ng or μg was determined using standards that were generated independently of experimental samples and
that contained abundant levels of each gene. *p<0.05, **p<0.01, ****p<0.0001 by two-way ANOVA with Sidak post-tests; means ± SD (n = 3).
doi:10.1371/journal.ppat.1005809.g005
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Fig 6. Mitochondrial stress contributes to IFNβ induction by MTBC strains. A-F) BMDMwere treated with MitoQ or control (dTPP) for 4 hours and
then infected with the indicated bacterial strains at an MOI of 5. A-B) 48 hr post infection supernatants were collected for IFNβ (A) and TNF (B) protein
quantification by ELISA. *p<0.05, ****p<0.0001 by two-way ANOVAwith Sidak post-tests; means ± SD (n = 3). IFNβ results are representative of 3
independent experiments. TNF comparison between control and MitoQ treatment is representative of 3 independent experiments, but the differences
in TNF between Mtb strains varied between experiments. C-D) Percent inhibition of IFNβ (C) or TNF (D) induction during MitoQ treatment was
calculated for each replicate (n = 3) during infection with each strain. Pearson correlation coefficient (r) of percent inhibition (y-axis) and cytokine
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IFNβ induction (Fig 7). Together these results show that the mechanism for IFNβ induction by
Mtb is much more complex than the established model suggests.
Mitochondria are integral centers in the cell that recognize and emit danger signals–such as
mtDNA and ROS–to direct cellular responses [37], including various innate immune responses
[32]. Here we have shown that mitochondrial dynamics contribute to the IFNβ response to
Mtb infection. This has already been shown in other pathological contexts. MtDNA instability
and accumulation of mtDNA in the cytosol contribute to the cGAS-mediated IFNβ response to
HSV-1 [28]. Additionally, systemic lupus erythematosus is associated with mitochondrial dys-
regulation and type I interferon signatures [38–40], oxidized mtDNA released from lupus neu-
trophils drives type I interferon [24], and mitochondrial antioxidants attenuate IFNβ responses
and lupus-like disease in mice [30]. Our finding that mitochondrial stress contributes to IFNβ
induction by distinct MTBC strains suggests that it will be worthwhile to determine how wide-
spread this pathway may be in other infections or diseases.
An important remaining question is how 1182/Lineage 6 induces less mitochondrial stress
than H37Rv/Lineage 4. It is possible that 1182/Lineage 6 secretes reduced levels of a virulence
factor that targets and disrupts mitochondria. Examples of such virulence factors in other path-
ogens include Staphylococcus aureus α-toxin and Streptococcus pneumoniae pneumolysin [41].
secretion (x-axis) is shown. G) Percent inhibition of IFNβ during MitoQ treatment. *p<0.05, **p<0.01 by one-way ANOVA with Tukey post-tests;
means ± SD (n = 3). F) Lysates from replicates (n = 3) of the experiment shown in Fig 6A–6E were pooled and CFU were quantified by serial dilution
on 7H11 agar plates.
doi:10.1371/journal.ppat.1005809.g006
Fig 7. Model for mycobacterial strain-dependent IFNβ induction.We propose a model in which mitochondrial stress and mtDNA contribute to
IFNβ induction by Mtb. 1182/Lineage 6 accesses the host cytosol to the same extent as H37Rv/Lineage 4 and 4334/Lineage 2. However, this strain
induces less mitochondrial stress and less accumulation of mtDNA in the cytosol, which contributes to lower IFNβ induction. H37Rv/Lineage 4
induces more mitochondrial stress and more accumulation of mtDNA in the cytosol, which contributes to increased IFNβ induction. Our data suggest
that 4334, and perhaps other strains, provide an additional cGAS signal that has not yet been discovered.
doi:10.1371/journal.ppat.1005809.g007
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1182/Lineage 6 contains a premature stop codon in Rv3879c of the Esx-1 gene locus [42],
which does not impact ESAT-6 secretion [14] but may impact the secretion of other virulence
factors. It is also possible that 1182/Lineage 6 secretes higher levels of an antioxidant that pre-
vents mitochondrial toxicity. A third possibility is that 1182/Lineage 6 secretes reduced levels
of a metabolite that feeds into the citric acid cycle and drives mitochondrial ROS. Succinate
secretion is upregulated in mycobacteria under conditions of hypoxia [43] and perhaps a simi-
lar metabolic change occurs upon macrophage entry that drives mitochondrial ROS. This func-
tion been proposed for citrate produced by Salmonella during infection [44]. These
possibilities are not mutually exclusive and studies are ongoing to address these questions.
Our results provide an alternative view of cytosolic signaling and IFNβ induction by Mtb
than previous studies. First, we show that IFNβ induction is not necessarily a measure of cyto-
solic access, as 1182/Lineage 6 induced lower levels of IFNβ than the other two bacterial strains
but, as indicated by three distinct assays, gained similar access to the host cytosol. Second, we
show that bacterial DNA is probably not the predominant danger signal in the cytosol during
Mtb infection; mtDNA released from stressed mitochondria likely binds cGAS to induce IFNβ.
We did not observe complete reduction in IFNβ with MitoQ treatment. This could be due to
residual superoxide and cytosolic mtDNA present in MitoQ-treated cells or it could be due to
an additional mechanism that acts in concert with mitochondrial stress to promote IFNβ sig-
naling. Perhaps bacterial DNA contributes to differential IFNβ induction but cannot be
detected by the gene-specific primers that we used in our assays. We propose that we were able
to discover this mechanism, while previous studies did not, for several reasons. First, we used
diverse clinical isolates to test the model. Second, we used low bacterial doses (MOI of 1, 5, or
10) throughout the study and carefully controlled for any effect that CFU might have had on
our results (Figs 1 and 6 and S2 Table). The study that showed mycobacterial DNA bound to
cGAS used a high dose of bacteria (MOI of 20) and did not show CFU or mtDNA results [12].
Our results are consistent with previous studies that showed that Lineage 2 strains induce
more IFNβ than Lineage 4 strains [45, 46]. This suggests that the ability to induce mitochon-
drial stress and/or IFNβmay contribute to the global dissemination and virulence of this line-
age [47]. However, further studies would be required to determine how widespread this
pathway is in Lineage 2. Our data also suggest that additional mechanisms exist for Lineage 2
strains to induce high levels of IFNβ, as 4334/Lineage 2 induced less mitochondrial stress than
H37Rv/Lineage 4. We propose that 4334/Lineage 2 induces cGAS signaling by an as of yet
undetermined mechanism. We noted that 4334/Lineage 2 interacted differently with FK2 and
Galectin-3 than H37Rv/Lineage 4 and 1182/Lineage 6, indicating that this strain may behave
differently in the host cytosol and may induce entirely distinct signaling pathways.
It also remains unknown if the reduced ability to induce mitochondrial stress and IFNβ is
widespread in Lineage 6 strains. If so, these factors likely played a role in the evolution of Line-
age 6. Lineage 6 strains exhibit low virulence and are geographically restricted to West Africa
[48]; reduced ability to induce mitochondrial stress and IFNβmay contribute to this attenua-
tion. Interestingly, Lineage 6 is currently not being outcompeted by Lineage 4 and Lineage 2 in
areas where it is prevalent [49, 50]. Thus reduced mitochondrial toxicity and the ability to
cause slower disease progression may have been selected for in Lineage 6, and future studies
are warranted to investigate this possibility.
Ultimately, understanding IFNβ induction by Mtb may facilitate the development of host-
directed TB treatments. Treating mice with prostaglandin E2 and zileuton, which limit IFNβ
induction, confers tolerance to Mtb [5] and zileuton has been developed as a drug that can be
administered to TB patients to enhance the efficacy of antibiotic treatment [51]. Our data sug-
gest that mitochondria-specific antioxidants could be another means to limit the pathogenic
type I interferon response. Studies that identify additional mechanisms by which Mtb induces
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type I interferon would then be indispensible as they could provide additional targets for TB
prevention and therapy.
Materials and Methods
Ethics statement
All animal experiments were done in accordance with procedures approved by the NYU School
of Medicine Institutional Animal Care and Use Committee (IACUC, Laboratory Animal Care
Protocol: 150502–01). These IACUC regulations conformed to the national guidelines provided
by the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Cell cultures
BMDM were generated from 8–12 week old wild-type C57BL/6 mice from The Jackson Labo-
ratory. BMDM were generated using 20% L929-cell-conditioned media for 7 days, unless oth-
erwise indicated. For antioxidant treatment, BMDM were treated with 0.25 μMMitoQ (gift
fromMichael Murphy, Ph.D., MRCMitochondrial Biology Unit, Cambridge, United King-
dom) or 0.25 μM decyltriphenylphosphonium bromide (Santa Cruz Biotechnology) for 4
hours prior to infection and throughout infection.
Bacterial strains and culture conditions
H37Rv/Lineage 4 was obtained from American Type Culture Collection, 1182/Lineage 6 was
obtained from an HIV-uninfected male with pulmonary tuberculosis in The Gambia (courtesy
of Bouke de Jong, M.D., Ph.D., Institute of Tropical Medicine, Antwerp, Belgium), and 4334/
Lineage 2 was obtained from a patient of unspecified HIV status with pulmonary tuberculosis
in San Francisco (courtesy of Diane Ordway, Ph.D., Colorado State University, Fort Collins,
USA and Midori Kato-Maeda, M.D., San Francisco General Hospital). Strains were grown at
37°C in Middlebrook 7H9 liquid or 7H11 solid media supplemented with 10% albumin, dex-
trose and catalase.
Bacterial infections
Bacteria were grown to exponential phase, resuspended in 0.5% PBS-Tween 80, and centri-
fuged at 150 g for 8 min to remove clumped and dead bacteria. OD580:CFU ratios were calcu-
lated individually for each strain. Bacteria were added to BMDM at the MOI reported in the
figure legend. Plates were incubated at 37°C under 5% CO2. Cells were washed 3–4 hr post
infection and given fresh BMDMmedia.
Cell fractionation
BMDM were infected in 6-well plates. Digitonin extracts were generated as previously
described [52], with the digitonin concentration optimized for our assays. 24 hr post infection,
cells were collected and resuspended in ice cold PBS. One eighth (by volume) of the suspension
was subjected to bead-beating to lyse BMDM and bacteria and saved as the undisturbed cell
normalization control. The remainder of the cells were resuspended in ice cold lysis buffer con-
taining 150 mMNaCl, 50 mMHEPES pH 7.4, and 0.01% digitonin (Sigma). The homogenates
were incubated end over end for 10 min at room temperature to allow selective membrane per-
meabilization and then centrifuged at 650 g for 5 min at 4°C to pellet intact cells. Supernatants
were transferred to fresh tubes and centrifuged at maximum speed (20,800 g) for 10 min at 4°C
to pellet organelles and obtain cytosolic supernatants. Organelle fractions were washed in PBS
and resuspended in TN1 lysis buffer (50 mM Tris pH 8, 150 mMNaCl, 10% glycerol, 1 mM
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EDTA, 0.1% Triton-X, protease inhibitor cocktail). Organelle and cytosolic fractions were fil-
tered with 0.22 μm SpinX filters (Corning). DNA and protein were extracted from undisturbed
cell and cytosolic fractions by phenol-chloroform separation. DNA was precipitated from the
aqueous phase using isopropanol. Protein was precipitated from the cytosolic fraction phenol
phase using 0.1M ammonium acetate in methanol [53].
qRT-PCR
BMDM were infected in 6-well plates. RNA was extracted at indicated time points using
RNeasy Mini Kits (Qiagen), DNA was removed using RQ1 RNase-Free DNase (Promega), and
cDNA was generated using Reverse Transcription System (Promega). IFNβ was normalized to
β-actin (ng IFNβ/ng β-actin). DNA was quantified directly following cell fractionation and
DNA precipitation. Cytosolic DNA was normalized to undisturbed cell DNA ((ng cytosolic
DNA)/(ng total undisturbed cell DNA)100). Amount in ng of each gene was determined
using standards that were generated independently of experimental samples and that contained
abundant levels of each gene. The sequences were as follows: IFNβ fwd CAGCTCCAAGAAAG
GACGAAC, rvs GGCAGTGTAACTCTTCTGCAT; β-actin fwd AGTGTGACGTTGACATC
CGTA, rvs GCCAGAGCAGTAATCTCCTTCT; D-loop fwd AATCTACCATCCTCCGTGAA
ACC, rvs TCAGTTTAGCTACCCCCCCAAGTTTAA; SigF fwd GCGGGTCGGGCTGGTCA
AC, rvs CCTCGCCCATGATGGTAGGAAC; dnaA fwd CGACAACGACGAGATTGATGA,
rvs CGGTAGCGGAATCGGTATTG.
ELISA
BMDM were infected in 24-well plates. 48 hr post infection cell culture supernatants were col-
lected from infected cells, filtered with 0.22 μm SpinX filters (Corning), and assayed for mouse
IFNβ (PBL Interferon Source) and TNF (eBioscience).
Fluorescence microscopy
BMDM were infected in Lab-Tek chamber slides. Cells were washed at indicated time points
and fixed in 1% PFA overnight at 4°C. Primary antibodies FK2 (Millipore) and Galectin-3
(eBioscience) and secondary antibodies Alexa Fluor 488 goat anti-mouse and Alexa Fluor 488
chicken anti-rat (Invitrogen) were used at 1:1000. Slides were visualized on a Leica Leitz
DMRB upright microscope. For superoxide analysis BMDM were incubated with 5 μMMito-
SOX in DMEM for 25 min at 37°C, washed in warm PBS, and fixed in 1% PFA overnight at
4°C. Slides were visualized on a Zeiss LSM710 Multiphoton microscope. Mean cell fluorescence
intensity was determined using ImageJ.
LiveBLAzer FRET assay
BMDMwere infected in black-wall, clear-bottom 96-well plates. 24 hr post infection CCF4-AM
with 2.5 μMprobenecid was added to cells at room temperature (LiveBLAzer FRET-B/G Loading
Kit; Invitrogen). After 2 hr cells were washed 3x in PBS with 2.5 μM probenecid. Cells were fixed
in 4% PFA for 30 min and then overnight in 1% PFA at 4°C. Slides were visualized on a Nikon
Eclipse Ti inverted microscope and 450nm:520nm ratios of the area directly surrounding each
bacterium were determined using NIS-Elements Imaging Software.
Luminescent ATP detection
BMDM were grown for 6 days using 20 ng/mL M-CSF (PeproTech) and then were plated in
96-well plates in M-CSF media without glucose and with 5 mM galactose. Cells were grown for
Type I Interferon Induction by Distinct Mycobacterial Strains
PLOS Pathogens | DOI:10.1371/journal.ppat.1005809 August 8, 2016 15 / 20
24 hours in the presence of galactose and absence of glucose prior to infection and throughout
infection. On day 7 BMDM were infected at the MOI reported in the text. 24 hr post infection
intracellular ATP was measured using a Luminescent ATP Detection Assay Kit (Abcam).
Immunoblotting
Protein from TN1 lysates or phenol extracts was denatured at 95°C for 5 min and quantified
using Pierce BCA Protein Assay Kit. Samples were normalized to total amount of protein, sepa-
rated by SDS-PAGE on 12% Tris-HCl gels (BioRad), and transferred onto 0.2 μm nitrocellulose
membranes. Blots were incubated with anti-β-actin (Cell Signaling), anti-Complex Vα
(Abcam), and anti-pyruvate dehydrogenase E1α (Abcam).
Supporting Information
S1 Table. Mycobacterial strains used in this study.
(PDF)
S2 Table. Differences in bacterial numbers and TNF do not explain differences in IFNβ
induction between MTBC strains. ANCOVAmodels were run with IFNβ secretion at 48 hr
post infection as the dependent variable, strain (1182, H37Rv, 4334) as a fixed factor, CFU col-
lected at 3, 24 and 48 hr post infection as a covariate, and TNF secretion at 48 hr post infection
as a covariate. No interactions were significant and therefore were removed from the models.
Analysis was done in SPSS.
(PDF)
S1 Fig. Access to the host cytosol does not vary by mycobacterial strain. A-B) BMDM were
infected with the indicated dsRed-expressing bacterial strains at an MOI of 10, and then incu-
bated with the LiveBLAzer FRET substrate at 24 hr post infection. Mtb in the cytosol cleaves
the substrate and disrupts FRET; emission signals at 520 nm indicate no Mtb cytosolic access
and emission signals at 450 nm indicate Mtb cytosolic access. A) Representative images are
shown, with bacterial strains shown in white, the 450 nm emission shown in magenta, and the
520 nm emission shown in green. B) Three images were taken at 20x magnification for each
well (3 wells per strain) and 450:520nm ratios were determined for the area directly surround-
ing each bacterium. Ratios were plotted on a histogram for each strain and fit to a Gaussian dis-
tribution using the linear regression function in Prism.
(TIF)
S2 Fig. mtDNA in the cytosol is positively correlated with IFNβ induction during Mtb
infection. A-C) BMDM were treated with MitoQ or control (dTPP) for 4 hours and then
infected with the indicated bacterial strains at an MOI of 5. 24 hr post infection supernatants
were collected for IFNβ quantification by ELISA and cells were fractionated. Amount of DNA
in cytosolic fractions was determined using gene-specific primers for mitochondrial (A),
nuclear (B), and bacterial (C) DNA; amount in ng was determined using standards that were
generated independently of experimental samples and that contained abundant levels of each
gene. Pearson correlation coefficient (r) of IFNβ induction (y-axis) and DNA in the cytosol (x-
axis) is shown. Results shown are from the same experiment as those shown in Fig 5C–5H.
(TIF)
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